Pharmacokinetics of serelaxin in patients with hepatic impairment: A single-dose, open-label, parallel group study
Kobalava Z.,
Villevalde S.,
Kotovskaya Y.,
Hinrichsen H.,
Petersen-Sylla M.,
Zaehringer A.,
Pang Y.,
Rajman I.,
Canadi J.,
Dahlke M.,
Lloyd P.,
Halabi A.
Связанные документы (рекомендация CORE)